Article
Effects of AGTR1 A1166C gene polymorphism in patients with heart failure treated with candesartan.
The Annals of pharmacotherapy - 1 Jul 2008
de Denus Simon, Zakrzewski-Jakubiak Marcin, Dubé Marie-Pierre, Bélanger François, Lepage Serge, Leblanc Marie-Hélène, Gossard Denis, Ducharme Anique, Racine Normand, Whittom Lucette, Lavoie Joel, Touyz Rhian M, Turgeon Jacques, White Michel
Abstract excerpt
BACKGROUND: The benefits of angiotensin II receptor blockers (ARBs) in patients with heart failure who are treated with standard pharmacotherapy, including an angiotensin-converting enzyme (ACE) inhibitor, were demonstrated in 2 large randomized trials. It is currently impossible to determine which patient will benefit from the addition of an ARB. OBJECTIVE: To explore the impact of selected candidate genes on...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
